達梭黴素涷晶注射劑

Land: Taívan

Tungumál: kínverska

Heimild: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Download Opinber matsskýrsla (PAR)
11-04-2020

Virkt innihaldsefni:

TAZOBACTAM (AS SODIUM);;PIPERACILLIN (SODIUM);;PIPERACILLIN (SODIUM);;TAZOBACTAM (AS SODIUM)

Fáanlegur frá:

輝瑞大藥廠股份有限公司 台北市信義區松仁路100號42、43樓 (37199708)

ATC númer:

J01CR05

Lyfjaform:

凍晶注射劑

Samsetning:

PIPERACILLIN (SODIUM) (0812691910) GM; TAZOBACTAM (AS SODIUM) (4410000710) MG; PIPERACILLIN (SODIUM) (0812691910) GM; TAZOBACTAM (AS SODIUM) (4410000710) MG

Einingar í pakka:

小瓶裝

Tegund:

製 劑

Gerð lyfseðils:

限由醫師使用

Framleitt af:

WYETH LEDERLE S.R.L. VIA FRANCO GORGONE, ZONA INDUSTRIALE IT-95100, CATANIA, ITALY IT

Lækningarsvæði:

piperacillin and beta-lactamase inhibitor

Ábendingar:

對PIPERACILLIN 具有感受性以及對PIPERACILLIN具抗藥性但對PIPERACILLIN?TAZOBACTAM 有感受性之B-LACTAMASE 產生菌株所引起之中至嚴重程度感染

Vörulýsing:

有效日期: 2025/07/04; 英文品名: TAZOCIN

Leyfisdagur:

2020-03-25

Upplýsingar fylgiseðill

                                
                                
                                Lestu allt skjalið